Ripretinib (DCC-2618)
CAS: 1442472-39-0
Ref. 3D-SHC47239
1mg | 189.00 € | ||
2mg | 272.00 € | ||
5mg | 399.00 € | ||
10mg | 498.00 € | ||
25mg | 711.00 € |
Product Information
Ripretinib is a potent, orally bioavailable inhibitor of the tyrosine kinase activity of RET. It has been shown to be effective in treating gastrointestinal cancer and solid tumours. This drug is metabolized by cytochrome P450 (CYP) enzymes and interacts with other drugs that are CYP substrates. Ripretinib also inhibits the activity of other cellular factors, such as cell factor (CF), which may contribute to its antitumour effects.
Chemical properties
Technical inquiry about: 3D-SHC47239 Ripretinib (DCC-2618)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.